These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 22085466)
21. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity. Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214 [TBL] [Abstract][Full Text] [Related]
22. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E. Bever CS; Scotcher M; Cheng LW; Hnasko RM; Stanker LH Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31337022 [TBL] [Abstract][Full Text] [Related]
23. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D. Garcia-Rodriguez C; Yan S; Geren IN; Knopp KA; Dong J; Sun Z; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564645 [TBL] [Abstract][Full Text] [Related]
24. Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology. von Berg L; Stern D; Pauly D; Mahrhold S; Weisemann J; Jentsch L; Hansbauer EM; Müller C; Avondet MA; Rummel A; Dorner MB; Dorner BG Sci Rep; 2019 Apr; 9(1):5531. PubMed ID: 30940836 [TBL] [Abstract][Full Text] [Related]
25. Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins. Nakamura K; Kohda T; Seto Y; Mukamoto M; Kozaki S Vet Microbiol; 2013 Mar; 162(2-4):881-890. PubMed ID: 23206412 [TBL] [Abstract][Full Text] [Related]
26. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Tomic MT; Espinoza Y; Martinez Z; Pham K; Cobb RR; Snow DM; Earnhart CG; Pals T; Syar ES; Niemuth N; Kobs DJ; Farr-Jones S; Marks JD Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30959899 [TBL] [Abstract][Full Text] [Related]
27. Enhancing toxin-based vaccines against botulism. Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477 [TBL] [Abstract][Full Text] [Related]
28. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay. Kalb SR; Baudys J; Kiernan K; Wang D; Becher F; Barr JR J Anal Toxicol; 2020 Mar; 44(2):173-179. PubMed ID: 31287544 [TBL] [Abstract][Full Text] [Related]
29. Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E. Rosen O; Feldberg L; Yamin TS; Dor E; Barnea A; Weissberg A; Zichel R Sci Rep; 2017 Nov; 7(1):14859. PubMed ID: 29093524 [TBL] [Abstract][Full Text] [Related]
30. Strategies to design inhibitors of Clostridium botulinum neurotoxins. Cai S; Singh BR Infect Disord Drug Targets; 2007 Mar; 7(1):47-57. PubMed ID: 17346211 [TBL] [Abstract][Full Text] [Related]
31. The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA. Fan Y; Barash JR; Conrad F; Lou J; Tam C; Cheng LW; Arnon SS; Marks JD Toxins (Basel); 2019 Dec; 12(1):. PubMed ID: 31877649 [TBL] [Abstract][Full Text] [Related]
32. Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations. Diamant E; Lachmi BE; Keren A; Barnea A; Marcus H; Cohen S; David AB; Zichel R PLoS One; 2014; 9(1):e87089. PubMed ID: 24475231 [TBL] [Abstract][Full Text] [Related]
33. Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species. Atassi MZ; Dolimbek BZ; Hayakari M; Middlebrook JL; Whitney B; Oshima M J Protein Chem; 1996 Oct; 15(7):691-700. PubMed ID: 8968960 [TBL] [Abstract][Full Text] [Related]
34. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain. Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786 [TBL] [Abstract][Full Text] [Related]
35. Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. Umeda K; Seto Y; Kohda T; Mukamoto M; Kozaki S J Clin Microbiol; 2009 Sep; 47(9):2720-8. PubMed ID: 19571018 [TBL] [Abstract][Full Text] [Related]
36. Botulinum neurotoxins and botulism: a novel therapeutic approach. Thanongsaksrikul J; Chaicumpa W Toxins (Basel); 2011 May; 3(5):469-88. PubMed ID: 22069720 [TBL] [Abstract][Full Text] [Related]
37. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. Barash JR; Arnon SS J Infect Dis; 2014 Jan; 209(2):183-91. PubMed ID: 24106296 [TBL] [Abstract][Full Text] [Related]
38. De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Kalb SR; Baudys J; Rees JC; Smith TJ; Smith LA; Helma CH; Hill K; Kull S; Kirchner S; Dorner MB; Dorner BG; Pirkle JL; Barr JR Anal Bioanal Chem; 2012 Apr; 403(1):215-26. PubMed ID: 22395449 [TBL] [Abstract][Full Text] [Related]
39. Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E. Miethe S; Rasetti-Escargueil C; Avril A; Liu Y; Chahboun S; Korkeala H; Mazuet C; Popoff MR; Pelat T; Thullier P; Sesardic D; Hust M PLoS One; 2015; 10(10):e0139905. PubMed ID: 26440796 [TBL] [Abstract][Full Text] [Related]
40. Development of highly sensitive chemiluminescence enzyme immunoassay based on the anti-recombinant H(C) subunit of botulinum neurotoxin type A monoclonal antibodies. Liu Z; Song C; Li Y; Liu F; Zhang K; Sun Y; Li H; Wei Y; Xu Z; Zhang C; Yang A; Xu Z; Yang K; Jin B Anal Chim Acta; 2012 Jul; 735():23-30. PubMed ID: 22713913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]